CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 14 enrolled
Drug / intervention
Botulinum toxin type A +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03799484
NCT03799484Phase 4Completed
CompareCT.gov

Randomized, Single Center, Masked Study Comparing the Efficacy of Botulinum Toxin Type A Injection After Topical Anesthesia Versus Petrolatum Ointment

The University of Texas Health Science Center, Houston·interventional·Posted Jan 10, 2019·Updated Jun 18, 2020

In Brief

A Phase 4 clinical trial evaluating Botulinum toxin type A, 2.5% lidocaine/2.5% prilocaine, and 1 other intervention for Forehead Rhytides and Forehead Wrinkles. Completed, enrolled 14 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether there is a difference in clinical effect, duration of effect, level of discomfort and patient satisfaction in patients receiving topical anesthesia on one side of the forehead and petrolatum ointment on the other prior to Botulinum Toxin Type A administration for the treatment of forehead rhytides.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsForehead Rhytides, Forehead Wrinkles
CountriesUnited States
CollaboratorsRobert Cizik Eye Clinic

Timeline

Phase 4CompletedFinished
20192020202120222023202420252026
First PostedJan 10, 2019
Enrollment StartJan 4, 2019
Primary CompletionJun 14, 2019
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 7.5 years ago

Interventions

Botulinum toxin type Adrug

Botulinum toxin type A will be administered to both sides

2.5% lidocaine/2.5% prilocainedrug

2.5% lidocaine/2.5% prilocaine will be applied to one side of the forehead

petrolatum ointmentdevice

petrolatum ointment will be applied to one side of the forehead